Jeffrey Schwartz Joins InClinica as Assistant Vice President of Business Development, Americas
PHILADELPHIA (July 11, 2018) – InClinica, a global clinical CRO, announced today that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development, representing the company’s operations throughout North and South America. In his new role, Mr. Schwartz will be responsible for new business development and market growth.
Schwartz has more than 22 years of executive leadership and business development experience in the pharmaceutical industry. Prior to joining InClinica, he served as Director of Recruitment and Business Development at TFS, where he oversaw the company’s recruitment processes and business development throughout the US.
“Jeff will make an excellent addition to the InClinica team,” said James Nolan, CEO at InClinica. “His deep knowledge of the pharmaceutical sector, coupled with his management and business development experience, will be a valuable asset to our organization.”
Schwartz received a Bachelor of Science in Management from the University of Phoenix. Before earning his bachelor’s, he served in the U.S. Navy during the Persian Gulf Conflict.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.